Who Owns Pliant Therapeutics Stock?
NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 78.55%
- Held by insiders
- 2.23%
- Institutional holders
- 110
- Institutions 78.6%
- Insiders 2.2%
- Public and other 19.2%
Who owns Pliant Therapeutics stock?
Institutional investors own about 78.6% of Pliant Therapeutics's shares, spread across 110 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.23% of PLRX.
The largest institutional holders are Tang Capital Management, LLC (9.92%), Adar1 Capital Management, LLC (8.90%) and Vanguard Capital Management LLC (3.94%). Together, the top 10 institutions control 45.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their PLRX positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PLRX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Tang Capital Management, LLC | 6.14M | 9.92% | -0.0% |
| Adar1 Capital Management, LLC | 5.51M | 8.90% | +113.1% |
| Vanguard Capital Management LLC | 2.44M | 3.94% | +4.2% |
| Acadian Asset Management. LLC | 2.42M | 3.90% | 0.0% |
| Two Sigma Investments, LP | 2.26M | 3.65% | +0.4% |
| Citadel Advisors Llc | 2.14M | 3.46% | -33.6% |
| Renaissance Technologies, LLC | 2.05M | 3.31% | +10.6% |
| Monaco Asset Management SAM | 1.94M | 3.13% | 0.0% |
| Lynx1 Capital Management Lp | 1.80M | 2.90% | +100.0% |
| BML Capital Management, LLC | 1.55M | 2.50% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PLRX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.75M | 2.82% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 615.80K | 0.99% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 471.33K | 0.76% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 322.27K | 0.52% |
| iShares Trust-iShares Micro-Cap ETF | 205.25K | 0.33% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 153.16K | 0.25% |
| Invesco Exchange-Traded Fund Trust-Invesco RAFI US 1500 Small-Mid ETF | 104.26K | 0.17% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 96.07K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 94.75K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 79.91K | 0.13% |
Frequently asked questions
Who is the largest shareholder of Pliant Therapeutics?
Tang Capital Management, LLC is the largest institutional shareholder of PLRX, owning 9.92% of shares outstanding (6.14M shares) as of its latest 13F filing.
What percentage of Pliant Therapeutics is owned by institutions?
Institutions own about 78.6% of PLRX shares and 80.3% of the public float.
How much of Pliant Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.23% of PLRX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.